Skip to main content
PMC home page
The Journal of Headache and Pain logoLink to The Journal of Headache and Pain
. 2009 Dec 18;11(1):13–19. doi: 10.1007/s10194-009-0179-2

A review of current European treatment guidelines for migraine

Fabio Antonaci 1,2,✉, Cezar Dumitrache 3, Ilaria De Cillis 1,2, Marta Allena 4
PMCID: PMC3452183  PMID: 20020170

Abstract

Migraine is one of the ten most disabling disorders worldwide, and despite recent developments in the management of migraine, it remains underdiagnosed and undertreated. Guidelines for the management of migraine aim to improve the quality of patient care and to assist professionals in decision making in relation to the overall healthcare process. Most European countries have published national clinical practice guidelines for migraine treatment. These guidelines need to be kept up-to-date with the most recent best clinical evidence and therapeutic strategies to ensure their optimal use to improve health outcomes. The aim of this review is to compare the English language guidelines available across Europe, analyzing differences and similarities, in order to provide a general overview to assist in assessing whether a European consensus on migraine treatment can be achieved.

Keywords: National guidelines, Migraine management, Stratified care, Stepped care

Full Text

The Full Text of this article is available as a PDF (150.6 KB).

Conflict of interest

None.

References

  • 1.Field MJ, Lohr KN (eds) (1990) Committee to advise the public health service on clinical practice guidelines, Institute of Medicine. Clinical practice guidelines: directions of a new program. National Academy Press, Washington, DC
  • 2.Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA. 1999;281:1900–1905. doi: 10.1001/jama.281.20.1900. [DOI] [PubMed] [Google Scholar]
  • 3.Natsch S, Meer JW. The role of clinical guidelines, policies and stewardship. J Hosp Infect. 2003;53(3):172–176. doi: 10.1053/jhin.2002.1372. [DOI] [PubMed] [Google Scholar]
  • 4.Headache Classification Committee of the International Headache Society Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1998;8(Suppl 7):1–96. [PubMed] [Google Scholar]
  • 5.Headache Classification Committee of the International Headache Society the international classification of headache disorders, 2nd edn. Cephalalgia. 2004;24(Suppl 1):1–160. doi: 10.1111/j.1468-2982.2003.00824.x. [DOI] [PubMed] [Google Scholar]
  • 6.Géraud G, Lanteri-Minet M, Lucas C, Valade D. French Society for the study of migraine headache (SFEMC). French guidelines for the diagnosis and management of migraine in adults and children. Clin Ther. 2004;26(8):1305–1318. doi: 10.1016/S0149-2918(04)80161-9. [DOI] [PubMed] [Google Scholar]
  • 7.Gallai V, Sarchielli P, for the Ad Hoc Committee for the Diagnostic and Therapeutic Guidelines of Migraine and Cluster Headache Diagnostic and therapeutic guidelines for migraine. Italian Society for the Study of Headaches (SISC) J Headache Pain. 2001;2:S125–S129. doi: 10.1007/s101940170025. [DOI] [Google Scholar]
  • 8.Jensen K. Guidelines for the management of headache. Danish Neurological Society and the Danish Headache Society. Cephalalgia. 1998;18(1):9–22. doi: 10.1046/j.1468-2982.1998.1801009.x. [DOI] [PubMed] [Google Scholar]
  • 9.Quality-control committee of the Netherlands Society of Neurology (1997) Guidelines for diagnostics and treatment of chronic migraine headache recurrence without neurological abnormalities. Netherlands Society for Neurology, Utrecht, The Netherlands
  • 10.Scottish Intercollegiate Guidelines Network (SIGN) The diagnosis and management of headache in adults. (Guideline No 107). SIGN, Edinburgh, 2008. Available via http://www.sign.ac.uk. Accessed 10 Mar 2009
  • 11.Société Suisse pour l’étude des céphalées (2008) Céphalées et algies faciales. Recommandations therapeutiques avec traitement des céphalées par le médecin de famille. Available via http://www.headache.ch/Therapieempfehlungen. Accessed 23 Mar 2009
  • 12.Farkkila M (2008) Finnish current care guideline migraine. The working group set up by the Finnish Medical Society Duodecim and The Finnish Society of Neurology. Available via http://www.ehf-org.org/guidelines/Pages/EHFGuidelines.aspx. Finnish Current Care Guideline Migraine, Accessed 10 Jun 2009
  • 13.British Association for the Study of Headache (2007) Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication-overuse headache, 3rd edn. Available via http://216.25.88.43/upload/NS_BASH/BASH_guidelines_2007.pdf. Accessed 10 Mar 2009
  • 14.Lainez JM, Castillo J, Gonzales VM, Otero M, Mateos V, Leira R, Pascual J. Guia de recomendaciones para el tratamiento de la migrana en la practica clinica. Rev Clin Esp. 2007;207(4):190–193. doi: 10.1157/13101849. [DOI] [PubMed] [Google Scholar]
  • 15.Stefanache F, Cuciureanu D. The headache and cranial neuralgias. In: Bajenaru O, editor. Diagnosis and treatment guidelines in neurology. Bucharest: Amaltea; 2006. pp. 140–195. [Google Scholar]
  • 16.Demarin V, Vukovic V, Lovrencic-Huzjan A, Lusic I, Janculjak D, Wilheim K. Evidence based guidelines for treatment of primary headaches. Acta Clin Croat. 2005;44:139–183. [PubMed] [Google Scholar]
  • 17.Demarin V, Vukovic V, Lovrencic-Huzjan A, Lusic I, Janculjak D, Wilheim K, Zurak N. Evidence based guidelines for treatment of primary headaches. Acta Med Croatica. 2008;62:99–136. [PubMed] [Google Scholar]
  • 18.Couturier EGM, Bomhof MAM, Gooskens RHJM, Keyser A, Mulleners WM (2007) Richtlijnen Diagnostiek en Behandeling Chronisch Recidiverende Hoofdpijn Zonder Neurologische Afwijkingen. Commissie Kwaliteit van de Nederlandse Vereniging voor Neurologie Werkgroep Richtlijnen Hoofdpijn. Available via http://www.neurologie.nl/uploads/136/1169/richtlijn_hoofdpijn_versie_2008.pdf. Accessed 08 Jun 2009
  • 19.Evers S, Afra J, Frese A, Goadsby PJ, Linde M, Sandor PS. EFNS guideline on the drug treatment of migraine—report of an EFNS task force. Eur J Neurol. 2006;13(6):560–572. doi: 10.1111/j.1468-1331.2006.01411.x. [DOI] [PubMed] [Google Scholar]
  • 20.Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sándor PS. EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force. Eur J Neurol. 2009;16(9):968–981. doi: 10.1111/j.1468-1331.2009.02748.x. [DOI] [PubMed] [Google Scholar]
  • 21.Steiner TJ. Lifting the burden: the global campaign against headache. Lancet Neurol. 2004;3:204–205. doi: 10.1016/S1474-4422(04)00703-3. [DOI] [PubMed] [Google Scholar]
  • 22.Steiner TJ, Paemelaire K, Jensen R, Valade D, Savi L, Lainez MJ, Diener HC, Martelletti P, Couturier EG (2007) European Headache Federation; lifting the burden: the global campaign to reduce the burden of headache worldwide, World Health Organization. European principles of management of common headache disorders in primary care. J Headache Pain Suppl 1:83–47 [DOI] [PubMed]
  • 23.Lampl C, Voelker M, Diener HCJ. Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. J Neurol. 2007;254(6):705–712. doi: 10.1007/s00415-007-0547-2. [DOI] [PubMed] [Google Scholar]
  • 24.Goadsby PJ, Zanchin G, Geraud G, et al. Early vs. non-early intervention in acute migraine-’Act when Mild (AwM)’. A double-blind, placebo-controlled trial of almotriptan. Cephalalgia. 2008;28:383–391. doi: 10.1111/j.1468-2982.2008.01546.x. [DOI] [PubMed] [Google Scholar]
  • 25.Lipton RB, Steward WF, Ryan RE, Jr, et al. Stratified care vs step care strategies for migraine. The Disability in Strategies of Care (DISC) Study: a randomized trial. JAMA. 2000;284:2599–2605. doi: 10.1001/jama.284.20.2599. [DOI] [PubMed] [Google Scholar]
  • 26.Sculpher M, Millson D, Meddis D, Poole L. Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: the Disability in Strategies of Care (DISC) Study. Pharmacoeconomics. 2002;20:91–100. doi: 10.2165/00019053-200220020-00002. [DOI] [PubMed] [Google Scholar]
  • 27.Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55:754–762. doi: 10.1212/wnl.55.6.754. [DOI] [PubMed] [Google Scholar]
  • 28.MacGregor EA, Brandes J, Eikermann A. Prevalence and treatment patterns: the global migraine and zolmitriptan evaluation Survey. Headache. 2003;43:19–26. doi: 10.1046/j.1526-4610.2003.03004.x. [DOI] [PubMed] [Google Scholar]
  • 29.Pavone E, Banfi R, Vaiani M, Panconesi A. Patterns of triptans use: a study based on the records of a community pharmaceutical department. Cephalalgia. 2007;27:1000–1004. doi: 10.1111/j.1468-2982.2007.01401.x. [DOI] [PubMed] [Google Scholar]
  • 30.Bigal ME, Borucho S, Serrano D, Lipton RB. The acute treatment of episodic and chronic migraine in the USA. Cephalalgia. 2009;29:891–897. doi: 10.1111/j.1468-2982.2008.01819.x. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Headache and Pain are provided here courtesy of BMC

RESOURCES